Introduction: In patients with acute coronary syndrome (ACS), hyperglycemia is a predictor of immediate and long-term cardiovascular mortality. Abnormal glucose regulation is present in the majority of these patients and is unrecognized in up to half of the cases. The objective of this study was to assess the glycaemic status of patients on admission with ACS. Methodology: Patients presenting with chest pain and falling into one of the acute coronary syndromes (STEMI, NSTEMI, and UA) were allocated in to two groups based on past history of Diabetes. Diagnosed Diabetic patients who were not on treatment were excluded from the study. Admission RBS and next day FBS were recorded in all patients. Results: 102 patients were enrolled for the study. Mean admission random blood sugar(RBS) and fasting blood sugar(FBS) of diabetic patients who were on treatment were significantly higher (308, 203 mg/dl) than that of patients without a past history of Diabetes (135, 111 mg/dl) P < 0.001. Out of the patients with diabetes, 88% had a RBS more than 140mg/dl and 59% had more than 200 mg/dl on admission. Patients without past history of Diabetes, these values were 32% and 5% respectively. 45% of patients without past history of Diabetes had impaired FBS values (100 -126 mg/dl) and 17% had a FBS value more than 126 mg/dl. The blood glucose values (RBS and FBS) of each of the three types of ACSs (STEMI, NSTEMI, UA) did not show a significant difference among them. Conclusions: Hyperglycaemia is a major problem in our patients with and without a past history of diabetes when they present with ACS. Therefore prompt attention is necessary on blood glucose control in all patients, irrespective of the past status of diabetes. It is important to follow up the patients with abnormal blood glucose values and without a past history of diabetes , to detect the development of Diabetes.
Introduction
In patients with acute coronary syndrome (ACS) 1 , hyperglycemia has been shown to be a predictor of immediate and long-term cardiovascular mortality 2 . Abnormal glucose regulation is present in the majority of ACS patients and is unrecognized in up to half of the cases 3 . Recent studies have addressed the impact of abnormal glucose metabolism in the acute phase of patients ACS and without diabetes 4 . The entity of impaired fasting glucose (IFG) is not only an independent factor of cardiovascular mortality, it has also been associated with a doubling of the risk of in-hospital mortality in ACS 5, 6 . It has also been found that stress hyperglycaemia due to myocardial infarction is associated with an increased risk of in-hospital mortality in patients with and without diabetes 7 . Recent trials have shown that in patients with ACS, the combination of fasting blood sugar (FBS) more than 110 mg/dl and an admission random blood sugar (RBS) of more than 140 mg/dl identifies patients who are prone to developing Diabetes later 8, 9 .
There is no published data in Sri Lanka regarding hyperglycaemia in patients presenting with ACS. There seams to be rise in prevalence of diabetes in Sri Lanka and this may have a significant impact on the prognosis of patients with ACS. The main objective of this study was to assess the glycaemic status of the patients with diabetes and patients without a past history of diabetes, on admission with ACS. 
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Results
Characteristics of the patients are shown in the Table 1 .The mean RBS values of the patients with and without a past history of diabetes were 308 mg/dl and 135 mg/dl respectively (P < 0.001). The mean FBS of known patients with and without a past history of diabetes were 203 mg/dl and 111 mg/dl respectively (P < 0.001).
Eighty eight percent of the patients with diabetes had admission RBS more than 140 mg/dl and 59% had more than 200 mg/dl. Of the patients without a past history of diabetes, 32 % had admission RBS value more than 140 mg/dl and 5.7% had an admission RBS value more than 200mg/dl. It was found that the 17% of patients without a past history of diabetes had a FBS value above 126mg/dl and 26% in the range of 100 -126 mg/dl.
The mean admission RBS values of STEMI, NSTEMI and UA were 188 mg/dl, 233mg/dl, 169 mg/dl respectively (P = 0.12). The mean FBS values of STEMI, NSTEMI and UA were 146mg/dl, 189 mg/dl, 139 mg/dl respectively (P = 0.07). The results are summarized in Table 2 .
Discussion
Diabetes mellitus is an established risk factor of poor prognosis of ACS and good glycemic control is valuable for a better outcome 10 . Admission blood glucose measurement allows planning therapeutic decisions at the acute phase. Stress hyperglycemia could also be a contributory factor in the causation of hyperglycaemia. In this study, we found that the glycaemic control of known diabetic patients on treatment was unsatisfactory. This could partly be due to the result of acute stress (stress hyperglycaemia) in those with proper diabetic control before the admission. The presence of hyperglycaemia in patients without a past diagnosis of diabetes was an interesting finding. Whether these patients had a significant stress hypeglycaemia or whether they were mainly undiagnosed patients with diabetes is debatable. Follow up studies and assessment of HbA1c levels of this
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High prevalence of impaired fasting glucose tolerance in patients with ACS indicates that this is an important event to screen all with a FBS test. Treating them early (at least life style modification) will improve the long term mortality and morbidity and may prevent progression to diabetes 11, 12 . The observation that the sub types of ACS (STEMI, NSTEMI, UA) did not show a significant difference in the blood glucose values suggest that the degree of myocardial necrosis do not directly correlate with the raised blood glucose levels.
This study illustrates that hyperglycaemia is a major problem in ACS patients, with and without a past history of diabetes, particularly so in those already known to have diabetes. Therefore, prompt attention is necessary to control blood glucose in all these patients, irrespective of the past status of diabetes. It is important to follow up the patients with abnormal blood glucose values and without a past history of diabetes, to detect the development of Diabetes. 
